Lysophosphatidic acid signaling in ovarian cancer

This publication has 69 references indexed in Scilit:

• Methods for quantifying lysophosphatidic acid in body fluids: A review
  Analytical Biochemistry, 2014
• Aiming drug discovery at lysophosphatidic acid targets
  British Journal of Pharmacology, 2010
• Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance
  Prostaglandins & Other Lipid Mediators, 2010
• Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer
  Journal of Gynecologic Oncology, 2010
• Lysophosphatidic acid (LPA) and its receptors
  Current Opinion in Pharmacology, 2009
• Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer Cells
  JNCI: Journal of the National Cancer Institute, 2008
• Inhibition of Lysophosphatidic Acid Receptor-2 Expression by RNA Interference Decreases Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Activation, Cell Invasion, and Migration in Ovarian Cancer SKOV-3 Cells
  Croatian Medical Journal, 2008
• The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms
  Gynecologic Oncology, 2007
• Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer
  Cancer Letters, 2003
• Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
  JAMA, 1998